Medical devices, healthcare technology and the business of care
510(k) clearance · K261714

FlowXL System: FlowXL Flowmeter and compatible Flowprobes and Flowsensors

Transonic Systems, Inc. · Decision date Oct 27, 2026

MEDTECHLEDGER EXPLANATIONK261714

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on 2026-10-27 for K261714, the FlowXL® System: FlowXL Flowmeter and compatible Flowprobes and Flowsensors, submitted by Transonic Systems, Inc. of Ithaca, NY. The filing was received 05/26/2026 as a traditional 510(k) under regulation 870.2100, product code DPW, with the Cardiovascular specialty and review panel. SESE means the submission was cleared to market; it is not a PMA approval.

The record identifies the device as a blood flowmeter system with compatible probes and sensors, but the public summary fields do not describe the specific components, changes, or performance data reviewed. The summary document is linked but its contents are not included here, so the basis for the equivalence finding remains unknown. The same decision appears in FDA's final-decision listing dated 27 Oct 2026.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Oct 27, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261714
Regulatory pathway
510(k) premarket notification
Product code
DPW
Decision code
SESE
Decision date
Oct 27, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Flowmeter, Blood, Cardiovascular.

Product code
DPW
FDA device class
2

FDA decision timeline

  1. K261714 received

    Application receipt date recorded by FDA.

  2. K261714 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Transonic Systems, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Ithaca, NY

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records